The chemical manufacturer affected natural resources to the tune of over $1 billion and contributed to a rise in cancer cases ...
Novartis (NYSE:NVS – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating ...
The pharmaceutical giant named Jeffrey Legos the head of a division it is counting on to overcome investor pressure and grow ...
At age 60, funny lady Sykes gets serious about her breast cancer journey and discusses life as a wife, mom, and professional.
Unlike other brands that release their ads days or weeks ahead of the Big Game, Novartis is waiting to unveil its commercial ...
Researchers discovered the importance of an enzyme that promotes growth of certain lung cancers. Lung cancer is a ...
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
Initially launching in Germany, the app will soon be available in the UK, Australia, Canada, and other markets.
After promoting its oncology officer Chris Boshoff to chief scientific officer last fall, Pfizer has found his successor.
In mid-2024, the commercial president of Pfizer’s oncology unit Suneet Varma announced his retirement after 15 years with the ...
Individual patient data from neoadjuvant randomized breast cancer clinical trials with available data on pathologic complete ...
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results